A Closer Look At Merck's Commercial Restructuring: What Happened To India?
This article was originally published in PharmAsia News
Executive Summary
In the latest overhaul of its commercial operations, Merck shared enthusiasm about prospects in emerging markets. But it did not include India, Turkey and Poland in its list of top 10 priority markets, a change from its vision shared just four years ago